| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT07198074 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin… |
Trial sites expanded: 206 -> 211 locations |
| 2026-06-12 | NCT07061977 Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… |
Trial sites expanded: 253 -> 260 locations |
| 2026-06-12 | NCT04090398 Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy… |
date change Primary completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-06-12 | NCT04090398 Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy… |
date change Completion pushed: 2026-06-30 -> 2027-06-30 |
| 2026-06-12 | NCT03907475 Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid… |
date change Primary completion pushed: 2026-06-01 -> 2027-06-01 |
| 2026-06-12 | NCT03907475 Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid… |
date change Completion pushed: 2026-06-01 -> 2027-06-01 |
| 2026-06-11 | NCT04332367 Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or… |
date change Primary completion pushed: 2026-04 -> 2026-09-30 |
| 2026-06-11 | NCT04332367 Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or… |
date change Completion pushed: 2026-04 -> 2026-09-30 |
| 2026-06-11 | NCT07044336 Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial… |
Enrollment increased: 700 -> 800 participants |
| 2026-06-11 | NCT07044336 Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial… |
Trial sites expanded: 314 -> 317 locations |
| 2026-06-11 | NCT07044336 Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial… |
date change Primary completion moved earlier: 2028-01-20 -> 2027-10-15 |
| 2026-06-10 | NCT07221474 A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in… |
Trial sites expanded: 47 -> 51 locations |
| 2026-06-09 | NCT06619236 Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in… |
Enrollment increased: 448 -> 530 participants |
| 2026-06-09 | NCT07419295 A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer… |
Trial sites expanded: 42 -> 50 locations |
| 2026-06-09 | NCT07216703 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… |
Trial sites expanded: 115 -> 125 locations |
| 2026-06-06 | NCT05017012 A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC)… |
Trial completed |
| 2026-06-06 | NCT05017012 A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC)… |
Enrollment increased: 72 -> 142 participants |
| 2026-06-06 | NCT07007559 ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in… |
Trial sites expanded: 32 -> 44 locations |
| 2026-06-06 | NCT05285358 Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine… |
Recruitment suspended |
| 2026-06-06 | NCT05285358 Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine… |
critical why stopped: null → "Pending Interim analysis" |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07640932 Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small… | Phase 2 | Not Yet Recruiting |
| 2026-06-08 | NCT07634094 Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and… | Phase 2 | Not Yet Recruiting |
| 2026-06-04 | NCT07628062 Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal… | Phase 2 | Not Yet Recruiting |
| 2026-06-02 | NCT07621718 Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of… | Phase 3 | Recruiting |
| 2026-06-01 | NCT07618910 Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC | Phase 2 | Not Yet Recruiting |
| 2026-05-22 | NCT07604766 An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of… | Phase 3 | Not Yet Recruiting |
| 2026-05-18 | NCT07594548 Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT03096418 | Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response | Breast Neoplasm Female | Recruiting |
| NCT05183126 | Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With… | Breast Cancer | Recruiting |
| NCT05689671 | Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung… | Non-Small Cell Lung Cancer Metastatic | Active, Not Recruiting |
| Phase 3 | |||
| NCT06644781 | A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic… | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT07218809 | AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low… | Epithelial Ovarian Cancer | Recruiting |
| NCT04342910 | Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With… | Gastric Cancer | Recruiting |
| NCT07284134 | JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced… | Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | Recruiting |
| NCT07377643 | IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in… | HER2-positive Breast Cancer | Recruiting |
| NCT06767527 | AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally… | Triple-Negative Breast Cancer (TNBC) | Recruiting |
| NCT06072781 | A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous… | Low Grade Serous Ovarian Cancer | Recruiting |
| NCT07168200 | A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy… | Advanced Cervical Cancer | Recruiting |
| NCT06828354 | A Study of SHR-A1811 in Subjects With Ovarian Cancer | Ovarian Cancer | Recruiting |
| NCT05357846 | PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally… | Squamous Cell Esophageal Carcinoma | Recruiting |
| NCT06103864 | A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's… | Breast Cancer | Recruiting |
| NCT04585490 | Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and… | Non Small Cell Lung Cancer | Recruiting |
| NCT05624996 | Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for… | Locally Advanced Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06958328 | Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer | Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma | Recruiting |
| NCT06989112 | DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or… | Endometrial Cancer | Recruiting |
| NCT03801876 | Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer | Clinical Stage I Esophageal Adenocarcinoma AJCC v8 | Recruiting |
| NCT06279364 | A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable… | Triple Negative Breast Cancer | Recruiting |
| NCT07071337 | A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With… | Metastatic Breast Cancer | Recruiting |
| NCT06623422 | A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in… | Carcinoma, Non-Small-Cell Lung | Recruiting |
| NCT07002346 | INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell… | Ovarian Clear Cell Carcinoma | Recruiting |
| NCT06340568 | A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy… | Endometrial Cancer | Recruiting |
| NCT06312137 | A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab… | Non Small Cell Lung Cancer | Recruiting |